Assessment of perioperative outcomes of surgery in patients with coronary heart disease and moderate ischemic mitral regurgitation
10.3760/cma.j.cn112434-20200709-00331
- VernacularTitle:外科治疗冠心病合并中度缺血性二尖瓣反流围手术期疗效分析
- Author:
Yue SONG
1
;
Ran DONG
;
Haiming DANG
;
Lisong WU
;
Jian CAO
;
Dong LIU
;
Qi HUANG
;
Xiaolong MA
Author Information
1. 首都医科大学附属北京安贞医院心脏外科 100029
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2020;36(10):613-616
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the perioperative effect of coronary artery bypass grafting(CABG) or CABG+ mitral valve repair(MVP) in patients with coronary heart disease(CAD) and moderate ischemic mitral regurgitation(IMR).Methods:The clinical data and perioperative complications of 210 patients with CAD and moderate IMR, who underwent CABG from January 2018 to December 2019, were included into this study, with 155 males and mean age of(62.3±8.5) years old. According to the operation mode, patients were divided into CABG group(138 cases) and CABG+ MVP group(72 cases).Results:There were no significant differences in age, gender, comorbidities(diabetes, hypertension, hyperlipidemia, peripheral vascular disease, cerebrovascular events, previous history of myocardial infarction and PCI), LVEF and of coronary artery lesions between the two groups(all P>0.05). Sequential anastomosis was the main method, and most patients underwent internal mammary artery graft in both groups, there was no significant difference between the two groups( P>0.05). CABG group was higher than CABG+ MVP group in all-cause death, heart failure, cerebrovascular events, secondary thoracotomy, CRRT and IABP support events, but there were no significant differences between the two groups( P>0.05). Echocardiographic reexamination showed that the indexes of cardiac function in CABG+ MVP group were higher than those in CABG group, but there was no significant difference between the two groups( P>0.05). The mean area of mitral regurgitation in CABG + MVP group was 1.3 cm 2, significantly lower than that in CABG group(2.5 cm 2), P<0.05. Conclusion:CABG+ MVP has low perioperative risk in patients with CAD and moderate IMR, and the area of mitral regurgitation is lower.
